Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia

Nature Genetics

Volumn 36, Issue 2, 2004, Pages 131-137

  Emamian, Effat S ^a,b   Hall, Diana ^a   Birnbaum, Morris J ^c   Karayiorgou, Maria ^a   Gogos, Joseph A ^b  

^a ROCKEFELLER UNIVERSITY   (United States)

^b Dept of Physiol and Cell Biophys ^*  (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; BRAIN PROTEIN; DIZOCILPINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; ENZYME ANTIBODY; GLYCOGEN SYNTHASE KINASE 3BETA; HALOPERIDOL; INOSITOL MONOPHOSPHATASE; ISOENZYME; LITHIUM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHOSPHATASE; PROTEIN KINASE; PROTEIN KINASE B; SERINE; THREONINE; TRANSCRIPTION FACTOR NFAT; TUBULIN; TYROSINE; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CELL LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; FEMALE; FRONTAL CORTEX; GENE IDENTIFICATION; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; MOUSE; NERVE CELL PLASTICITY; NERVE CONDUCTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; STARTLE REFLEX; SYNAPTIC TRANSMISSION;

ANTIPSYCHOTIC AGENTS; GLYCOGEN SYNTHASE KINASE 3; HALOPERIDOL; HAPLOTYPES; HUMANS; PHOSPHORYLATION; PHOSPHOTRANSFERASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SCHIZOPHRENIA; SERINE; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0842310838     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1296     Document Type: Article

References (30)

1. Coyle, J.T. & Duman, R.S. Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 38, 157-160 (2003).
2. Greengard, P. Neurobiology of slow synaptic transmission. Science 294, 1024-1029 (2001).
3. Winder, D.G. et al. ERK plays a regulatory role in induction of LTP by θ frequency stimulation and its modulation by β-adrenergic receptors. Neuron 24, 715-726 (1999).
4. Lin, C.H. et al. A Role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala. Neuron 31, 841-851 (2001).
5. Cho, H., Thorvaldsen, J.L., Chu, Q., Feng, F. & Birnbaum, M.J. Akt1/PKBβ is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J. Biol. Chem. 276, 38349-38352 (2001).
6. Braff, D.L., Geyer, M.A. & Swerdlow, N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl.) 156, 234-258 (2001).
7. Torrey, F., Webster, M., Knable, M., Johnston, N. & Yolken, R.H. The Stanley Foundation brain collection and Neuropathology Consortium. Schiz. Res. 44, 151-155 (2000).
8. Vanhaesebroeck, B. & Alessi, D.R. The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J. 346, 561-576 (2000).
9. Detera-Wadleigh, S.D. et al. A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2. Proc. Natl. Acad. Sci. USA 96, 5604-5609 (1999).
10. Segurado, R. et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am. J. Hum. Genet. 73, 49-62 (2003).
11. Toyota, T., Yamada, K., Detera-Wadleigh, S.D. & Yoshikawa, T. Analysis of a cluster of polymorphisms in AKT1 gene in bipolar pedigrees: a family-based association study. Neurosci. Lett. 339, 5-8 (2003).
12. Swerdlow, N.R. & Geyer, M.A. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr. Bull. 24, 285-301 (1998).
13. Blume-Jensen, P. & Hunter, T. Oncogenic kinase signaling. Nature 411, 355-365 (2001).
14. Chalecka-Franaszek, E. & Chuang, D.M. Lithium activates the serine/threonine kinase AKT-1 and suppresses glutamate-induced inhibition of AKT-1 activity in neurons. Proc. Natl. Acad. Sci. USA 96, 8745-8750 (1999).
15. De Sarno, P., Li, X. & Jope, R.S. Regulation of AKT and glycogen synthase kinase-3 β phosphorylation by sodium valproate and lithium. Neuropharmacology 43, 1158-1164 (2002).
16. Berrettini, W.H. Are schizophrenic and bipolar disorders related? A review of family and molecular studies. Biol. Psychiatry 48, 531-538 (2000).
17. Scheid, M.P. & Woodgett, J.R. PKB/AKT: functional insights from genetic models. Nat. Rev. Mol. Cell Biol. 2, 760-768 (2001).
18. Harwood, A.J. Regulation of GSK-3: a cellular multiprocessor. Cell 105, 821-824 (2001).
19. Markus, A., Zhong, J. & Snider, W.D. Raf and AKT mediate distinct aspects of sensory axon growth. Neuron 35, 65-76 (2002).
20. Beffert, U. et al. Reelin-mediated signaling locally regulates protein kinase B/AKT and glycogen synthase kinase-3β. J. Biol. Chem. 277, 49958-49964 (2002).
21. Knable, M.B., Torrey, E.F., Webster, M.J. & Bartko, J.J. Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium. Brain Res. Bull. 55, 651-659 (2001).
22. Li, B.S. et al. Cyclin-dependent kinase-5 is involved in neuregulin-dependent activation of phosphatidylinositol 3-kinase and Akt activity mediating neuronal survival. J. Biol. Chem. 278, 35702-35709 (2003).
23. Wang, Q. et al. Control of synaptic strength, a novel function of Akt. Neuron 38, 915-928 (2003).
24. Akama, K.T. & McEwen, B.S. Estrogen stimulates postsynaptic density-95 rapid protein synthesis via the Akt/protein kinase B pathway. J. Neurosci. 23, 2333-2339 (2003).
25. Mizuno, M. et al. Phosphatidylinositol 3-kinase: a molecule mediating BDNF-dependent spatial memory formation. Mol. Psychiatry 8, 217-224 (2003).
26. Graef, I.A. et al. L-type calcium channels and GSK-3 regulate the activity of NF-ATc4 in hippocampal neurons. Nature 401, 703-708 (1999).
27. Gerber, D.J. et al. Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit. Proc. Natl. Acad. Sci. USA 100, 8993-8998 (2003).
28. Miyakawa, T. et al. Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc. Natl. Acad. Sci. USA 100, 8987-8992 (2003).
29. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet. Epidemiol. 25, 115-121 (2003).
30. Lewontin, R.C. On measures of gametic disequilibrium. Genetics 120, 849-852 (1988).